| Literature DB >> 17209110 |
Abstract
Participants are often not informed by investigators who conduct randomised, placebo-controlled acupuncture trials that they may receive a sham acupuncture intervention. Instead, they are told that one or more forms of acupuncture are being compared in the study. This deceptive disclosure practice lacks a compelling methodological rationale and violates the ethical requirement to obtain informed consent. Participants in placebo-controlled acupuncture trials should be provided an accurate disclosure regarding the use of sham acupuncture, consistent with the practice of placebo-controlled drug trials.Entities:
Mesh:
Year: 2007 PMID: 17209110 PMCID: PMC2598073 DOI: 10.1136/jme.2006.016535
Source DB: PubMed Journal: J Med Ethics ISSN: 0306-6800 Impact factor: 2.903